Emtricitabine Completed Phase 2 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection Other

IndicationsStatusPurposePhase
CompletedOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT00743340Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine